
|Articles|February 15, 2019
Disease-Modifying Therapies for Duchenne Muscular Dystrophy: An Update for Managed Care Professionals
https://www.pharmacytimes.org/on-demand/diseasemodifying-therapies-for-duchenne-muscular-dystrophy-an-update-for-managed-care-professionals-ondemand-webinar
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Shifts in Colorectal Cancer Screening Trends After COVID-19
2
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
3
Challenges, Opportunities in Implementing the MDPP: Melanie T. Turk, PhD, RN
4
Real-World Evidence in Atopic Dermatitis: Patient-Reported Outcomes and Topical Therapy Effectiveness
5